Every public signal F4 has attached to this firm, with sources and cross-entity links.
Essay
Dimension published "At The Limit" letter (July 2026), the firm's annual letter to limited partners covering firm strategy and market perspective at the intersection of science and compute.
Dimension announced Dimension III, an $800M fund — 60% larger than its $500M Fund II raised 18 months earlier. The firm now manages $1.65B in assets and has backed 35 companies.
Dimension-backed anti-aging startup NewLimit, co-founded by Coinbase CEO Brian Armstrong, completed a Series C at a $3.1B valuation in July 2026. Dimension led the Series A in January 2025.
Simon Barnett, Partner at Dimension, co-authored an essay "Don't Fall in Love with Your Molecule" on the Dimension Research blog, discussing drug discovery decision-making.
"Don't Fall in Love with Your Molecule" by Simon Barnett
Dimension portfolio company Coefficient Bio (Coefficient Labs), a stealth drug discovery platform, was acquired by AI giant Anthropic for $400M in April 2026. Dimension received shares in Anthropic as part of the deal.